KINGDON CAPITAL MANAGEMENT, L.L.C. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2018$927,000
-94.7%
51,600
-91.3%
0.14%
-88.6%
Q3 2018$17,415,000
+2.7%
592,959
+59.0%
1.22%
+2.7%
Q2 2018$16,960,000
+48.7%
372,988
+72.7%
1.18%
+31.3%
Q1 2018$11,406,000
-4.6%
216,024
+22.9%
0.90%
+16.9%
Q4 2017$11,957,000
-32.8%
175,842
-18.6%
0.77%
-33.5%
Q3 2017$17,795,000
+153.8%
215,962
+188.4%
1.16%
+142.0%
Q2 2017$7,011,000
+270.2%
74,881
+263.5%
0.48%
+426.4%
Q3 2015$1,894,00020,6000.09%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders